ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,006Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 78

$1.19M Total Retail Price of All Prescriptions

Rank: 8 out of 78

677 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 677 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

4% of this provider’s 677 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 7,633 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$108 was the average price of a prescription from this provider, compared to $146 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
GABAPENTIN 661 471 1 6
METHOTREXATE 618 434 2 2
PREDNISONE 516 420 3 1
ROPINIROLE HCL 490 272 4 34
CYMBALTA 425 298 5 12
HYDROXYCHLOROQUINE SULFATE 419 312 6 3
TRAMADOL HCL 404 261 7 5
VENLAFAXINE HCL 370 294 10 8 50
PRAMIPEXOLE DIHYDROCHLORIDE 327 200 9 44
ALLOPURINOL 249 199 10 9
OMEPRAZOLE 238 207 11 17
VENLAFAXINE HCL ER 217 117 12 52
CITALOPRAM HBR 161 124 13 53
TIZANIDINE HCL 153 101 14 18
ENBREL 146 90 15 13
BISOPROLOL-HYDROCHLOROTHIAZIDE 138 86 16 68
LEVOTHYROXINE SODIUM 134 90 17 30
LEFLUNOMIDE 134 83 17 8
TOPIRAMATE 133 71 19 36
METFORMIN HCL 129 82 20 56
CHLOROQUINE PHOSPHATE 124 73 10 21 80
TRAZODONE HCL 121 113 22 24
PANTOPRAZOLE SODIUM 116 85 23 84
PROMETHAZINE HCL 113 69 R 24 49
FOLIC ACID 113 97 24 19
AMLODIPINE BESYLATE 112 97 26 40
ABILIFY 105 47 27 88
BUPROPION HCL SR 97 66 28 90
ZONISAMIDE 92 81 29 92
LYRICA 89 67 30 15
SERTRALINE HCL 88 63 31 51
HYDROCHLOROTHIAZIDE 84 44 32 42
HUMIRA 78 47 33 16
ESTRADIOL 73 34 R 34 103
OLANZAPINE 70 54 35 107
RISPERIDONE 68 36 36 110
HYDROCODONE-ACETAMINOPHEN 67 54 S3 37 4
SIMVASTATIN 64 48 38 41
LOSARTAN-HYDROCHLOROTHIAZIDE 63 30 39 114
MIRTAZAPINE 61 41 40 115
ATENOLOL 61 57 40 55
ACTONEL 57 54 42 63
CELEBREX 57 41 42 14
QUETIAPINE FUMARATE 56 31 44 126
ALENDRONATE SODIUM 55 43 45 10
LISINOPRIL 55 52 45 46
CYCLOBENZAPRINE HCL 54 32 R 47 11
ESCITALOPRAM OXALATE 53 35 48 132
IMIPRAMINE HCL 52 40 R 49 137
LEVETIRACETAM 51 0 50 140
MELOXICAM 50 36 51 7
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.